Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000355083

Medchemexpress LLC ErSO-DFP | 2768139-76-8 | 99.6% | C20H17F5N2O2 | 50 MG
SDP

Catalog No. 5000355083
Encompass_Preferred

ErSO-DFP is an anticipatory unfolded protein response (a-UPR) activator. It demonstrates enhanced selectivity for estrogen receptor alpha-positive (ERα+) cancer cells, offering a wider selectivity window. This compound exhibits antitumor activity against MCF-7 in mice and can effectively cross the blood-brain barrier.

  • Anticipatory unfolded protein response (a-UPR) activator
  • Enhanced selectivity for estrogen receptor alpha-positive (ERα+) cancer cells
  • Wider selectivity window
  • Displays antitumor activity against MCF-7 in mice
  • Can cross the blood-brain barrier

Catalog No. 50-003-55083 Supplier Medchemexpress LLC Supplier No. HY14407050MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

ErSO-DFP is an anticipatory unfolded protein response (a-UPR) activator. It demonstrates enhanced selectivity for estrogen receptor alpha-positive (ERα+) cancer cells, offering a wider selectivity window. This compound exhibits antitumor activity against MCF-7 in mice and can effectively cross the blood-brain barrier.

  • Anticipatory unfolded protein response (a-UPR) activator
  • Enhanced selectivity for estrogen receptor alpha-positive (ERα+) cancer cells
  • Wider selectivity window
  • Displays antitumor activity against MCF-7 in mice
  • Can cross the blood-brain barrier

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.